Auris Medical Holding مُعامِل القيمة السوقية للمبيعات 2024

ماذا تفعل Auris Medical Holding؟

Auris Medical Holding Ltd is a biopharmaceutical company that was founded in 2013 and is headquartered in Zug, Switzerland. The company specializes in the development and marketing of products in the field of hearing and hearing impairment. The history of Auris Medical Holding Ltd began with the founding of the company by Thomas Meyer and Daniel J. Salomon, both of whom had extensive experience in the biotech industry and investment banking. The company went public on the NASDAQ stock exchange in 2014 and has since expanded its business steadily. Auris Medical's business model is based on the development of innovative therapies and medications for disorders in the ENT field. The company focuses on the needs of patients with hearing and hearing impairment due to neurosensory disorders. In this area, there are currently only a few approved therapies, which represents a significant unmet medical need. Auris Medical divides its activities into two divisions: the development of clinical therapies and the marketing of products for the treatment of tinnitus and hearing loss. In the field of clinical therapies, the company specializes in the development of medications for restoring hearing. Among other things, Auris Medical is working on the development of AM-111, a treatment for acute inner ear damage that can lead to sudden hearing loss. Auris Medical also operates its own distribution chain, which offers products for the treatment of tinnitus and hearing loss. These products are marketed under the name Tinnitool and include devices for relieving tinnitus and hearing loss. The company also offers audiology services to perform individual audiological evaluations. Overall, Auris Medical Holding Ltd has a wide range of products aimed at the needs of patients with hearing and hearing impairment. From medications to symptom relief products to diagnostic services, the company is able to address various aspects of the health issue. As an innovative company, Auris Medical Holding Ltd invests heavily in research and development of new therapies and medications. The company collaborates with leading experts in the field of hearing and hearing impairment to improve its technologies and products. Additionally, the company aims to expand into further regions to reach a broader patient base. In summary, Auris Medical Holding Ltd is an emerging company in the field of hearing and hearing impairment. With a wide product portfolio tailored to the needs of patients, the company invests in research and development to develop new therapies and medications. Through its innovation and strong partnerships in the field of hearing and hearing impairment, the company plans to establish itself as a leading company in this field. Auris Medical Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.